CB23892-1 - 0x0000000000003440

Study Number: CB23892
Group Number: 1
Study Requirement: Healthy Normal Female
Stipend: $7,190.00

Study Criteria:

  • Age: 18 - 55
  • BMI: 18 - 32
  • Weight Restriction: minimum weight 111 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat cancer.
  • Route of Administration: Oral
  • Blood Draws: 47

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One - 9 Night Stay, One - 11 Night Stay, 9 Returns & 1 Phone Call

Screening Dates:

Event Day Event Date Site
Monday 1/22/2018 Phoenix
Thursday 1/25/2018 Phoenix

Doctor Exam Dates:

Event Day Event Date Site
Tuesday 1/30/2018 Phoenix

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 2/5/2018 11:00:00 AM Wednesday 2/14/2018 8:30:00 AM 1 Phoenix
Return Thursday 2/15/2018 7:30:00 AM Thursday 2/15/2018 8:30:00 AM 1 Phoenix
Return Friday 2/16/2018 7:30:00 AM Friday 2/16/2018 8:30:00 AM 1 Phoenix
Return Monday 2/19/2018 5:00:00 AM Monday 2/19/2018 10:00:00 AM 2 Phoenix
Return Tuesday 2/20/2018 7:00:00 AM Tuesday 2/20/2018 10:00:00 AM 2 Phoenix
Return Wednesday 2/21/2018 7:00:00 AM Wednesday 2/21/2018 10:00:00 AM 2 Phoenix
Return Thursday 2/22/2018 7:00:00 AM Thursday 2/22/2018 10:00:00 AM 2 Phoenix
Return Friday 2/23/2018 7:00:00 AM Friday 2/23/2018 10:00:00 AM 2 Phoenix
Return Saturday 2/24/2018 7:00:00 AM Saturday 2/24/2018 10:00:00 AM 2 Phoenix
Return Sunday 2/25/2018 7:00:00 AM Sunday 2/25/2018 10:00:00 AM 2 Phoenix
Check-In Monday 2/26/2018 5:00:00 AM Friday 3/9/2018 8:30:00 AM 2 Phoenix
Phone participant* Tuesday 3/13/2018 8:00:00 AM 2 Phoenix